COSM
Income statement / Annual
Last year (2024), Cosmos Health Inc.'s total revenue was $54.43 M,
an increase of 1.97% from the previous year.
In 2024, Cosmos Health Inc.'s net income was -$22.38 M.
See Cosmos Health Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$54.43 M |
$53.38 M |
$50.35 M |
$56.24 M |
$55.41 M |
$39.68 M |
$37.08 M |
$30.01 M |
$6.76 M |
$533,802.00 |
| Cost of Revenue |
$50.12 M
|
$49.03 M
|
$44.39 M
|
$47.91 M
|
$47.35 M
|
$36.01 M
|
$34.68 M
|
$28.06 M
|
$6.15 M
|
$484,809.00
|
| Gross Profit |
$4.31 M
|
$4.35 M
|
$5.96 M
|
$8.33 M
|
$8.06 M
|
$3.66 M
|
$2.41 M
|
$1.96 M
|
$601,040.00
|
$48,993.00
|
| Gross Profit Ratio |
0.08
|
0.08
|
0.12
|
0.15
|
0.15
|
0.09
|
0.06
|
0.07
|
0.09
|
0.09
|
| Research and Development Expenses |
$533,293.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$11.73 M
|
$24.36 M
|
$12.61 M
|
$11.68 M
|
$4.19 M
|
$3.29 M
|
$3.59 M
|
$4.85 M
|
$794,099.00
|
$486,036.00
|
| Selling & Marketing Expenses |
$354,969.00
|
$1.20 M
|
$630,057.00
|
$732,545.00
|
$763,170.00
|
$234,037.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$12.09 M
|
$25.57 M
|
$13.24 M
|
$12.41 M
|
$4.95 M
|
$3.52 M
|
$3.59 M
|
$4.85 M
|
$794,099.00
|
$486,036.00
|
| Other Expenses |
$7.23 M
|
$614,377.00
|
$188,890.00
|
$449,692.00
|
$397,595.00
|
$394,628.00
|
$43,930.00
|
$1.98 M
|
$9,448.00
|
$5,416.00
|
| Operating Expenses |
$19.86 M
|
$26.18 M
|
$13.43 M
|
$12.86 M
|
$5.35 M
|
$3.92 M
|
$3.64 M
|
$6.83 M
|
$803,547.00
|
$491,452.00
|
| Cost And Expenses |
$69.97 M
|
$75.21 M
|
$57.82 M
|
$60.77 M
|
$52.69 M
|
$39.93 M
|
$38.31 M
|
$34.89 M
|
$6.96 M
|
$976,261.00
|
| Interest Income |
$406,449.00
|
$662,859.00
|
$236,349.00
|
$46,316.00
|
$65,865.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1,063.00
|
| Interest Expense |
$1.01 M
|
$866,476.00
|
$3.97 M
|
$3.58 M
|
$2.80 M
|
$1.73 M
|
$6.81 M
|
$1.64 M
|
$206,014.00
|
$90,379.00
|
| Depreciation & Amortization |
$1.25 M
|
$614,377.00
|
$188,890.00
|
$449,692.00
|
$397,595.00
|
$394,628.00
|
$43,930.00
|
$25,903.00
|
$9,448.00
|
$5,416.00
|
| EBITDA |
-$13.92 M |
-$17.06 M |
-$8.90 M |
-$3.82 M |
$4.39 M |
-$988,585.00 |
-$2.19 M |
-$4.54 M |
-$384,769.00 |
-$6.59 M |
| EBITDA Ratio |
-0.26
|
-0.32
|
-0.18
|
-0.07
|
0.08
|
-0.02
|
-0.06
|
-0.15
|
-0.06
|
-12.35
|
| Operating Income Ratio |
-0.29
|
-0.41
|
-0.15
|
-0.08
|
0.05
|
-0.01
|
-0.03
|
-0.16
|
-0.03
|
-0.83
|
| Total Other Income/Expenses Net |
-$638,188.00
|
$3.29 M
|
-$5.58 M
|
-$3.31 M
|
-$1.52 M
|
-$2.86 M
|
-$7.81 M
|
-$1.33 M
|
-$397,726.00
|
-$6.25 M
|
| Income Before Tax |
-$16.18 M
|
-$18.54 M
|
-$13.06 M
|
-$7.85 M
|
$1.20 M
|
-$3.12 M
|
-$9.04 M
|
-$6.21 M
|
-$600,233.00
|
-$6.69 M
|
| Income Before Tax Ratio |
-0.3
|
-0.35
|
-0.26
|
-0.14
|
0.02
|
-0.08
|
-0.24
|
-0.21
|
-0.09
|
-12.53
|
| Income Tax Expense |
$6.20 M
|
$0.00
|
$775,051.00
|
$114,010.00
|
$377,535.00
|
$182,815.00
|
$17,326.00
|
$2,801.00
|
$769.00
|
$203.00
|
| Net Income |
-$22.38 M
|
-$18.54 M
|
-$13.83 M
|
-$7.96 M
|
$820,786.00
|
-$3.30 M
|
-$9.06 M
|
-$6.21 M
|
-$601,002.00
|
-$6.69 M
|
| Net Income Ratio |
-0.41
|
-0.35
|
-0.27
|
-0.14
|
0.01
|
-0.08
|
-0.24
|
-0.21
|
-0.09
|
-12.53
|
| EPS |
-1.17 |
-2.15 |
-33.16 |
-23.74 |
1.55 |
-6.21 |
-17.02 |
-12.25 |
-1.25 |
-13.31 |
| EPS Diluted |
-1.17 |
-2.15 |
-33.16 |
-23.74 |
1.54 |
-6.21 |
-17.02 |
-12.25 |
-1.2 |
-13.31 |
| Weighted Average Shares Out |
$19.15 M
|
$11.97 M
|
$1.93 M
|
$656,933.00
|
$530,803.00
|
$530,943.00
|
$532,264.00
|
$506,919.00
|
$480,801.00
|
$502,463.00
|
| Weighted Average Shares Out Diluted |
$19.15 M
|
$11.97 M
|
$1.93 M
|
$656,933.00
|
$532,311.00
|
$530,943.00
|
$532,264.00
|
$511,200.00
|
$502,592.00
|
$502,463.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
